Reduction of intestinal trimethylamine by probiotics ameliorated lipid metabolic disorders associated with atherosclerosis

Shivappa, 2018, Dietary inflammatory index and cardiovascular risk and mortality—A meta-analysis, Nutrients, 10, 200, 10.3390/nu10020200 Li, 2017, Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: A prognostic marker for incident cardiovascular events beyond traditional risk factors, Eur Heart J, 38, 814 Kuka, 2014, Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation, Life Sci, 117, 84, 10.1016/j.lfs.2014.09.028 Hoyles, 2018, Metabolic retroconversion of trimethylamine N-oxide and the gut microbiota, Microbiome, 6, 73, 10.1186/s40168-018-0461-0 Bergeron, 2016, Diets high in resistant starch increase plasma levels of trimethylamine-N-oxide, a gut microbiome metabolite associated with CVD risk, Br J Nutr, 116, 2020, 10.1017/S0007114516004165 Roberts, 2018, Development of a gut microbe–targeted nonlethal therapeutic to inhibit thrombosis potential, Nature Med, 24, 1407, 10.1038/s41591-018-0128-1 Ottiger, 2016, Trimethylamine-N-oxide (TMAO) predicts fatal outcomes in community-acquired pneumonia patients without evident coronary artery disease, Eur J Int Med, 36, 67, 10.1016/j.ejim.2016.08.017 Huang, 2018, Enterococcus faecium WEFA23 from infant lessens high-fat-diet-induced hyperlipidemia via cholesterol 7-alpha-hydroxylase gene by altering the composition of gut microbiota in rats, J Dairy Sci, 101, 7754, 10.3168/jds.2017-13713 Qiu, 2018, Lactobacillus plantarum ZDY04 exhibits a strain-specific property of lowering TMAO via the modulation of gut microbiota in mice, Food Funct, 9, 4299, 10.1039/C8FO00349A Qiu, 2017, Enterobacter aerogenes ZDY01 attenuates choline-induced trimethylamine N-oxide levels by remodeling gut microbiota in mice, J Microbiol Biotechnol, 27, 1491, 10.4014/jmb.1703.03039 García-Cañas, 2019, Screening gut microbial trimethylamine production by fast and cost-effective capillary electrophoresis, Analyt Bioanalyt Chem, 411, 2697, 10.1007/s00216-019-01716-2 Huang, 2010, The probiotic Lactobacillus acidophilus reduces cholesterol absorption through the down-regulation of Niemann-Pick C1-like 1 in Caco-2 cells, Br J Nutr, 103, 473, 10.1017/S0007114509991991 Lv, 2019, Screening of intestinal peristalsis-promoting probiotics based on a zebrafish model, Food Funct, 10, 2075, 10.1039/C8FO02523A Karimi, 2016, In vivo and in vitro detection of luminescent and fluorescent Lactobacillus reuteri and application of red fluorescent mCherry for assessing plasmid persistence, PLoS One, 11, 10.1371/journal.pone.0151969 Zhao, 2019, Trimethylamine N-oxide attenuates high-fat high-cholesterol diet-induced steatohepatitis by reducing hepatic cholesterol overload in rats, World J Gastroenterol, 25, 2450, 10.3748/wjg.v25.i20.2450 Zeisel, 2017, Trimethylamine N-oxide, the microbiome, and heart and kidney disease, Ann Rev Nutr, 37, 157, 10.1146/annurev-nutr-071816-064732 Hartmann, 2018, Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice, Hepatology, 67, 2150, 10.1002/hep.29676 Via, 2019, Urinary TMAO levels are associated with the taxonomic composition of the gut microbiota and with the choline TMA-lyase gene (cutC) harbored by Enterobacteriaceae, Nutrients, 12, 62, 10.3390/nu12010062 Randrianarisoa, 2016, Relationship of serum trimethylamine N-oxide (TMAO) levels with early atherosclerosis in humans, Sci Rep, 6, 26745, 10.1038/srep26745 Matsumoto, 2017, Bifidobacterium animalis subsp. lactis LKM512 reduces levels of intestinal trimethylamine produced by intestinal microbiota in healthy volunteers: A double-blind, placebo-controlled study, J Funct Foods, 36, 94, 10.1016/j.jff.2017.06.032 Chen, 2019, Oolong tea extract and citrus peel polymethoxyflavones reduce transformation of L-carnitine to trimethylamine-N-oxide and decrease vascular inflammation in L-carnitine feeding mice, J Agric Food Chem, 67, 7869, 10.1021/acs.jafc.9b03092 Mao, 2016, Lactulose differently modulates the composition of luminal and mucosal microbiota in C57BL/6J mice, J Agric Food Chem, 64, 6240, 10.1021/acs.jafc.6b02305 Tang, 2019, Intestinal microbiota in cardiovascular health and disease: JACC State-of-the-art review, J Am Coll Cardiol, 73, 2089, 10.1016/j.jacc.2019.03.024 Wang, 2015, Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis, Cell, 163, 1585, 10.1016/j.cell.2015.11.055 Bennett, 2013, Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation, Cell Metab, 17, 49, 10.1016/j.cmet.2012.12.011 Anbazhagan, 2017, Gut microbiota in vascular disease: Therapeutic target?, Curr Vasc Pharmacol, 15, 291 Wang, 2011, Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease, Nature, 472, 57, 10.1038/nature09922 Koeth, 2013, Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis, Nature Med, 19, 576, 10.1038/nm.3145 Tang, 2015, Probiotic therapy to attenuate weight gain and trimethylamine-N-oxide generation: A cautionary tale, Obesity, 23, 2321, 10.1002/oby.21250 Yang, 2019, Gut microbiota-dependent marker TMAO in promoting cardiovascular disease: Inflammation mechanism, clinical prognostic, and potential as a therapeutic target, Front Pharmacol, 10, 1360, 10.3389/fphar.2019.01360 Roselli, 2018, Beneficial effects of a selected probiotic mixture administered to high fat-fed mice before and after the development of obesity, J Funct Food, 45, 321, 10.1016/j.jff.2018.03.039 Kang, 2018, Anti-obese effects of a mixture of fermented ginseng, Bifidobacterium longumBORI, and Lactobacillus paracaseiCH88 in high-fat diet-fed mice, J Microbiol Biotechnol, 28, 10.4014/jmb.1801.01016 Chen, 2016, Resveratrol attenuates trimethylamine-N-oxide (TMAO)-induced atherosclerosis by regulating TMAO synthesis and bile acid metabolism via remodeling of the gut microbiota, Mbio, 7, 10.1128/mBio.02210-15 Thomas, 2010, Genome-wide tissue-specific Farnesoid X receptor binding in mouse liver and intestine, Hepatology, 51, 1410, 10.1002/hep.23450 Ramírez-Pérez, 2017, The role of the gut microbiota in bile acid metabolism, Ann Hepatol, 16, 15, 10.5604/01.3001.0010.5672